Eissa, I.H.; Yousef, R.G.; Elkady, H.; Alsfouk, A.A.; Alsfouk, B.A.; Husein, D.Z.; Ibrahim, I.M.; Elkaeed, E.B.; Metwaly, A.M.
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life 2023, 13, 191.
https://doi.org/10.3390/life13010191
AMA Style
Eissa IH, Yousef RG, Elkady H, Alsfouk AA, Alsfouk BA, Husein DZ, Ibrahim IM, Elkaeed EB, Metwaly AM.
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life. 2023; 13(1):191.
https://doi.org/10.3390/life13010191
Chicago/Turabian Style
Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, Aisha A. Alsfouk, Bshra A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Eslam B. Elkaeed, and Ahmed M. Metwaly.
2023. "A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study" Life 13, no. 1: 191.
https://doi.org/10.3390/life13010191
APA Style
Eissa, I. H., Yousef, R. G., Elkady, H., Alsfouk, A. A., Alsfouk, B. A., Husein, D. Z., Ibrahim, I. M., Elkaeed, E. B., & Metwaly, A. M.
(2023). A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life, 13(1), 191.
https://doi.org/10.3390/life13010191